In prostate cancer, androgen hormone induces the activity of transcriptional regulator, ERG, which increases the expression of CXCR4 thereby enhancing the pro-tumoural effects of CXCL12-CXCR4 signalling pathway (153). Here, CXCR4 is linked to prostate carcinoma.